CD274 and non-small cell lung carcinoma: The miR-34a family further exemplifies the therapeutic potential of miRNA modulation; downregulation of miR-34a in NSCLC and pancreatic cancer is associated with increased PD-L1 expression and diminished immune surveillance, whereas restoration of miR-34a reduces immune evasion and potentiates ICI efficacy[78].